Compare VRCA & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRCA | MBBC |
|---|---|---|
| Founded | 2013 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 33.5M |
| IPO Year | 2018 | N/A |
| Metric | VRCA | MBBC |
|---|---|---|
| Price | $7.24 | $12.87 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 192.6K | 3.0K |
| Earning Date | 03-10-2026 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | ★ $30,829,000.00 | $7,299,708.00 |
| Revenue This Year | $373.20 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $112.94 |
| Revenue Growth | ★ 234.73 | 7.77 |
| 52 Week Low | $3.28 | $8.74 |
| 52 Week High | $9.82 | $12.89 |
| Indicator | VRCA | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 67.33 |
| Support Level | $7.79 | $11.75 |
| Resistance Level | $8.20 | $12.40 |
| Average True Range (ATR) | 0.59 | 0.29 |
| MACD | -0.20 | 0.03 |
| Stochastic Oscillator | 1.38 | 100.00 |
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.